06.03.2013 • NewsAshlandpharmaceutical industrypharma R&D

Ashland to Expand Pharmaceutical Center of Excellence in Delaware

Ashland today announced plans to expand its pharmaceutical research and development Center of Excellence at the Ashland Research Center in Wilmington. Ashland will be expanding its existing capabilities to include formulation development and Good Manufacturing Processes (GMP) contract manufacturing services for solid dispersions and oral solid dosages.

To support early-stage clinical trials, the expansion will include spray drying and extrusion processes previously located in Columbia, Md. Approximately 20 positions will be relocated from Columbia to Wilmington in connection with the expansion.

The company expects the new facility to be operational by summer 2014. Ashland currently has pharmaceutical technology centers in Buenos Aires, Argentina; Sao Paulo, Brazil; Shanghai, China; Düsseldorf, Germany; Hyderabad, India; Istanbul, Turkey; and Mexico City, Mexico, in addition to Wilmington.

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.